Stanford University
Showing 13,001-13,100 of 13,136 Results
-
Yanxian Zhang
Postdoctoral Scholar, Endocrinology and Metabolism
BioThrough my academic training and research experience, I have cultivated a strong foundation in engineering and molecular biology. My work involves integrating diverse concepts from disciplines such as chemical engineering, protein engineering, supramolecular chemistry, and biophysics to address complex biomedical challenges. As a graduate student with Dr. Jie Zheng, my research focused on both natural and synthetic macromolecules. My research involved utilizing polymer chemistry to design biocompatible multifunctional hydrogels, as well as investigating the thermodynamics of amyloid proteins associated with neurodegenerative diseases. Leveraging my expertise in thermodynamics and supramolecular chemistry, I contributed to the study of understanding protein misfolding and aggregation. I identified sequence-independent inhibitors to prevent protein misfolding and developed a rational strategy for inhibitor design, enabling cross-interaction activity and the fluorescent detection of amyloids. Driven by a strong interest in translational research, I pursued postdoctoral training here at Stanford School of Medicine. In Dr. Danny Hung-Chieh Chou's lab at Stanford University, I received comprehensive training in peptide engineering and molecular biology. I am dedicated to addressing formulation challenges for insulin with stable ultra-concentrated and ultra-fast properties, aimed at miniaturizing insulin pumps and advancing the next-generation of insulin automatic delivery systems. This work is supported by the JDRF postdoctoral fellowship. Furthermore, I am working on therapeutics development and have successfully developed an insulin derivative that acts as a full insulin receptor antagonist. This development holds promise as a candidate for treating the rare disease of hyperinsulinism. Throughout my postdoctoral training, I have gained proficiency in grant writing, public speaking, and mentoring students. These experiences have significantly strengthened my skills as an independent investigator. Looking forward, my research goal is to develop innovative strategies that support the functionality and delivery of biological therapies.
-
Yizi Zhang
Postdoctoral Scholar, Neurosurgery
BioYizi Zhang is a postdoctoral scholar at the Neural Prosthetics Translational Lab and the Linderman Lab. Yizi’s research centers on scalable, data-driven approaches to neural encoding and decoding, with a recent emphasis on foundation models for brain-computer interfaces. Yizi is broadly interested in developing AI-assisted neuroprosthetic technologies to help individuals with paralysis communicate and interact more effectively with the world.
-
Yu Zhang
Assistant Professor (Research) of Psychiatry and Behavioral Sciences (Public Mental Health and Population Sciences)
BioDr. Yu Zhang's research operates at the intersection of AI, translational neuroscience, and precision medicine. His work focuses on unraveling the complex neurobiological mechanisms underlying cognitive deficits, behavioral dysfunctions, and therapeutic responses in mental health disorders. By integrating advanced machine learning techniques with multimodal brain imaging modalities (e.g., fMRI, DTI, EEG), Dr. Zhang aims to identify neural signatures that reveal the heterogeneity of mental disorders across individuals. A central goal of his research is the development and validation of robust neurobiomarkers to improve diagnostic accuracy, refine prognostic assessments, and guide personalized treatment strategies. His work systematically characterizes brain function and dysfunction to optimize therapeutic interventions, including pharmacological treatments, psychotherapy, and neurostimulation. He is particularly focused on conditions such as Alzheimer’s disease and related dimentia, mood disorders, and neurodevelopmental disorders (e.g., ADHD, ASD), where individualized approaches are essential for improving patient outcomes.
Dr. Zhang has received multiple grants including the NIH R01, R21, Eagles Autism Foundation Translational Grant, Alzheimer's Association Research Grant (AARG), and the Knight Initiative for Brain Resilience and the Rosenkranz Foundation Grants. Beyond foundational research, Dr. Zhang is committed to bridging the gap between computational innovation and clinical application. By collaborating with clinicians, neuroscientists, and engineers, he strives to translate data-driven insights into actionable tools for real-world healthcare settings. His long-term vision is to enable mental health diagnostics and treatment to be guided by objective, biologically grounded biomarkers, thereby enhancing quality of life and long-term outcomes for individuals with psychiatric and neurological conditions.
The Stanford Precision NeuroIntelligence (SPNI) Lab, led by Dr. Zhang, is dedicated to advancing research in AI-driven neuroimaging and precision psychiatry. The lab develops and applies cutting-edge machine learning and deep learning methods to uncover neurobiological mechanisms associated with cognitive and behavioral dysfunctions, as well as treatment responses in mental health conditions. Its mission is to identify translational biomarkers that support precision diagnosis, prognosis, and targeted interventions for mood disorders, neurodevelopmental disorders, and neurodegenerative diseases. -
Yuan Zhang
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioYuan Zhang, MD is a board certified family physician who enjoys providing both pediatric and adult care in disease screening, prevention, diagnosis, and treatment, including performing common office procedures. She has special interests in preventative medicine, women's health, and pediatric and adolescent health. She firmly believes that continued clinical excellence is rooted in lifelong learning - both from up-to-date clinical guidelines and from the lived experiences of her patients. She strives to deliver evidence-based care that is also compassionate and patient-centered.
-
Yuan Zhang
Basic Life Research Scientist, Psych/Major Laboratories and Clinical & Translational Neurosciences Incubator
Current Role at StanfordBasic Life Research Scientist
-
Zeyuan Zhang
Postdoctoral Scholar, Hematology-Oncology
BioZeyuan Zhang, Ph.D., is a Postdoctoral Scholar at Stanford University in the laboratory of Glaivy Batusli, where he is conducting research on the evolution of antibody development against the coagulation protein factor IX in hemophilia B disease models. He earned his Ph.D. in Biomedical Science from the University of Iowa, focusing on cell and developmental biology.
Dr. Zhang’s research centers on the molecular mechanisms underlying metabolic disease, with particular emphasis on organelle dysfunction in obesity. His work has provided insights into GSNOR enzymatic activity, lysosomal dysfunction, and inflammatory stress in metabolic regulation. He has also investigated transcriptional mechanisms contributing to obesity-associated hepatic dysfunction and adipose tissue homeostasis. Prior to joining Stanford, he worked as a Scientist I at Altos Labs, where he studied hepatocyte-specific rejuvenation reprogramming in fatty liver disease.
His technical expertise includes multi-omics approaches, RNA sequencing, chromatin immunoprecipitation, high-resolution respirometry, advanced imaging techniques, and in vivo mouse models. He also has extensive experience in primary cell isolation and histological analysis.
Dr. Zhang is interested in translational research that connects molecular mechanisms to therapeutic strategies, with the goal of developing innovative treatments for metabolic diseases. -
Kanhao (Alex) Zhao
Postdoctoral Scholar, Psychiatry
BioDr. Zhao is a postdoctoral researcher at Stanford University specializing in computational neuroscience, neuroimaging, and integrative multi-omics approaches to brain health. His research integrates supervised and unsupervised machine learning, functional neuroimaging, microbiome sequencing, metabolomics, and large-scale clinical datasets (e.g., Alzheimer's Disease Neuroimaging Initiative and National Health and Nutrition Examination Survey) to investigate how modifiable risk factors such as obesity, diet, and gut dysbiosis contribute to accelerated brain aging, cognitive vulnerability, and psychiatric symptoms.
His work focuses on developing multimodal frameworks that combine functional brain connectivity, cognitive and emotional phenotyping, microbiome profiles, and metabolomic signatures to uncover biological mechanisms underlying early cognitive decline and neuropsychiatric disorders. Through these approaches, Dr. Zhao aims to identify personalized intervention strategies—including dietary modification, microbiome-targeted therapies, and metabolite-guided treatments—to mitigate obesity-related brain aging and reduce the risk of cognitive impairment, Alzheimer's disease, anxiety, and depression.
In addition to translational neuroscience research, Dr. Zhao develops machine learning and computational methods for biomarker discovery, disease prediction, and precision psychiatry. His recent work also explores autonomous AI research agents and self-improving computational systems for large-scale neuroimaging and multi-omics foundational analysis. His publications were in online Nature Mental Health, Molecular Psychiatry, JAMA Network Open. He serves as a peer reviewer for leading journals, including Nature Mental Health, Medical Image Analysis, IEEE Transactions on Medical Imaging, npj Digital Health, and Neuropsychopharmacology. -
Liming Zhao
Affiliate, Stem Cell Bio Regenerative Med Institute
BioDr. Zhao is currently a postdoctoral scholar at Stanford University. He received his MD degree from Tongji Medical College, Huazhong University of Science and Technology in 2018.
-
Man Zhao
Postdoctoral Scholar, Radiation Biology
BioMy research primarily focuses on the molecular mechanisms, signaling pathways, and therapeutic targets underlying cancer metabolism, particularly the m6A demethylase FTO. I am also actively exploring the interplay between tumor metabolism and tumor immunity, with the goal of identifying novel metabolic vulnerabilities for cancer treatment.
-
Haoqi (Nina) Zhao
Assistant Professor of Civil and Environmental Engineering
BioNina joined Stanford CEE as an Assistant Professor in Summer 2026. Her research bridges computational metabolomics and exposomics to uncover unknown lifestyle chemicals and their impacts on health. Nina earned her B.S. from Peking University, her Ph.D. from the University of Washington, and was a postdoctoral scientist at UC San Diego. She received the Pathway to Independence Award (K99/R00) from the National Institutes of Health in 2025.
The Zhao Lab at Stanford will operate at the interface of environmental chemistry, environmental health, and computational mass spectrometry. We aim to identify previously unrecognized chemical drivers that influence human and ecosystem health. We pursue this goal by developing innovative computational and analytical methods centered around untargeted mass spectrometry. Through these efforts, we aim to enable precision environmental health strategies, inform public health policies, and inspire sustainable chemical design.
Current research interests include (but are not limited to):
1.Leveraging mass spectrometry data repositories and advanced informatics tools to systematically map the chemical exposome.
2.Developing tools and resources for mass spectrometry data analysis to advance exposomics research.
3.Investigating host-microbiome-xenobiotic interactions and their impacts on human health.
4.Integrating toxicology with untargeted screening to accelerate the discovery and risk assessment of unknown molecules.
5.Pediatric environmental health: chemical exposures through breastfeeding and their implications for infant development.
6.Traffic-related chemical pollution: environmental fate, occurrence, and relevance to human exposures.
Education
Ph.D., University of Washington, Environmental Engineering (2021)
B.S., Peking University, Environmental Science (2016)
Publications
https://scholar.google.com/citations?user=xW9jBO0AAAAJ&hl=en
Email: hqzhao@stanford.edu -
Renee Zhao
Assistant Professor of Mechanical Engineering and, by courtesy, of Bioengineering and of Materials Science and Engineering
BioRuike Renee Zhao is an Assistant Professor of Mechanical Engineering at Stanford University, where she directs the Soft Intelligent Materials Laboratory. Originally from the historic city of Xi'an, she earned her BS from Xi'an Jiaotong University in 2012. She then pursued Solid Mechanics at Brown University, obtaining her MS in 2014 and PhD in 2016. Following her doctoral studies, she completed postdoctoral training at MIT (2016–2018) before serving as an Assistant Professor at The Ohio State University (2018–2021).
Renee’s research focuses on developing stimuli-responsive soft composites for multifunctional robotic systems with integrated shape-changing, assembly, sensing, and navigation capabilities. By integrating mechanics, material science, and advanced material manufacturing, her work enables innovations in soft robotics, miniaturized biomedical devices, robotic surgery, origami systems, active metamaterials, and general deployable morphing structures.
Her contributions have been recognized with honors and awards, including the Presidential Early Career Award for Scientists and Engineers (PECASE), DARPA Young Faculty Award (YFA, 2025), ARO Early Career Program (ECP) Award (2023), AFOSR Young Investigator Research Program (YIP) Award (2023), Eshelby Mechanics Award for Young Faculty (2022), ASME Henry Hess Early Career Publication Award (2022), ASME Pi Tau Sigma Gold Medal (2022), ASME Applied Mechanics Division Journal of Applied Mechanics Award (2021), NSF CAREER Award (2020), and ASME Applied Mechanics Division Haythornthwaite Research Initiation Award (2018). She is also recognized as a National Academy of Sciences Kavli Fellow and was named one of MIT Technology Review's 35 Innovators Under 35. -
Tianyu Zhao
Postdoctoral Scholar, Radiation Biology
Current Research and Scholarly InterestsHow p53 affects the tissue homeostasis in lung cancer and injury.
-
Yanan Zhao
Postdoctoral Scholar, Psychiatry
BioYanan completed her Ph.D. degree at Fudan University, where she uncovered the mechanisms of sleep transitions from the evolutionary point of view in Dr Zhili Huang’s lab, with a combination of optogenetics, in vivo electrophysiology, fiber photometry, polysomnography, immunohistochemistry and so on. In the de Lecea lab, Yanan is now curious about how sleep regulates the balance between DNA damage and repair with approaches of imaging. At the same time, she is interested in larger scale imaging during different brain states. Outside the lab, Yanan enjoys biking and exploring the sunny bay area.
-
Yihan Zhao
Research Asst - Graduate, Biomedical Data Science
Bio* Part-time Adult, Lover for Hiking, Photograph, Jazz, Surfing, Pool
* AI4Health
* How Human make better AI? How AI make better Human?
* I want to make: Anticancer Drugs, Contraceptive for Male, Artificial Womb, Weight Loss Pills
Don't create opium, create a forest, create air and water -
Moss Zhao
Instructor, Neurosurgery
BioDr. Moss Zhao is an Instructor at Department of Neurosurgery, Stanford University. He develops cutting-edge and clinically viable imaging technologies to improve the diagnosis and treatment of cerebrovascular diseases across the lifespan. His specific areas of expertise include physiological modeling, arterial spin labeling, Bayesian inference, PET/MRI, and artificial intelligence. His scientific contributions could significantly improve the early detection of strokes and dementia as well as enrich the knowledge of brain development in the first two decades of life.
Dr. Zhao received his DPhil at St Cross College of University of Oxford under the supervision of Prof. Michael Chappell. As an alumni mentor, he supports the career development of students of his alma mater. Since 2016, he has presented his work to more than 3000 delegates at international conferences and held leadership positions in professional societies. His research and teaching are supported by the American Heart Association, the National Institutes of Health, and the European Cooperation in Science and Technology. -
Hong Zheng
Research Engineer, Med/BMIR-ITI Institute
BioMy research focuses on understanding the multi-omic landscape (genomics, epigenomics, transcriptomics, etc.) and immune responses in human diseases (cancer, aging, and infectious diseases, etc.), and identifying robust gene signatures and targets for disease diagnostics, prognostics, and therapeutics.
-
Xiaoxu Zhong
Postdoctoral Scholar, Radiation Physics
BioI am a Postdoctoral Fellow in the Guillem Pratx Lab, with an expertise in predictive modeling, algorithm development, and data science. I earned my Bachelor of Science and Master of Science degrees in Ocean Engineering from Shanghai Jiao Tong University. I then received a Ph.D. in Mechanical Engineering from Purdue University, where I focused on developing mathematical models and applying machine learning. My work uncovered the mechanisms behind autoinjectors, drug delivery, and cavitation bubbles, with applications in tumor treatment and the design of medical devices. Currently, I am combining computational modeling and experimental approaches to positron emission tomography imaging, aiming to improve tumor diagnosis and treatment. I am also investigating how ionizing radiation nucleates nano-sized bubbles.
-
Anna Ting Zhou
Clinical Assistant Professor, Surgery - Plastic & Reconstructive Surgery
BioDr. Anna Ting Zhou is a board-certified, fellowship-trained plastic surgeon with Stanford Health Care. She is also a clinical assistant professor in the Department of Surgery, Division of Plastic & Reconstructive Surgery at Stanford University School of Medicine.
Dr. Zhou performs a wide range of plastic and reconstructive surgeries to restore both function and appearance for patients affected by cancer and trauma. She specializes in breast reconstruction following breast-conserving surgery (lumpectomy) and mastectomy, offering the full spectrum of reconstruction options. Dr. Zhou also specializes in advanced surgical techniques to prevent and treat lymphedema. She performs procedures such as immediate lymphatic reconstruction, lymphovenous bypass, and vascularized lymph node transfer, helping restore lymphatic drainage and improve patients' quality of life.
A patient-centered approach guides Dr. Zhou’s practice. She believes that successful reconstruction begins with listening carefully to each patient's concerns, understanding their goals, and working together to develop a personalized surgical plan. She is dedicated to delivering compassionate, evidence-based care and partnering with each patient throughout their reconstructive journey.
Dr. Zhou's research focuses on advancing reconstructive microsurgery and improving outcomes in breast reconstruction and lymphedema surgery. Her work has explored techniques to preserve breast sensation following mastectomy and novel methods of hybrid breast reconstruction. She has also investigated the use of a medical implant to augment lymphedema surgery and how to optimize lymphedema treatment algorithms. She has authored numerous peer-reviewed publications in leading journals, including Plastic and Reconstructive Surgery, Journal of Surgical Oncology, and Journal of Clinical Medicine, and has presented her research at national and international scientific meetings.
Dr. Zhou is an active member of the American Society of Plastic Surgeons, the California Society of Plastic Surgeons, and the American Society for Reconstructive Microsurgery. -
Jiayan Zhou
Affiliate, Medicine - Med/Cardiovascular Medicine
BioI am a Senior Computational Genomics Scientist at the Palo Alto Veterans Institute for Research (PAVIR) and was previously a Postdoctoral Scholar leading the identification of genes responsible for cardiovascular disease in the Division of Cardiovascular Medicine, School of Medicine, Stanford University, and the VA Palo Alto Health Care System. My research focuses on population genetics and precision public health.
-
Maggie Zhou
Instructor, Medicine - Oncology
BioDr. Zhou is an Instructor in the Division of Oncology at Stanford University with an academic focus in sarcoma. She graduated from Yale University with a B.A. and double majored in economics and molecular, cellular, and developmental biology. She subsequently received her M.D. from Stanford University School of Medicine, where she completed her internal medicine residency and fellowship training.
Her research interests center around the development of novel therapeutics, understanding pathophysiology of rare sarcoma subtypes, and evaluating the utility of circulating tumor DNA for assessing disease response and detecting minimal residual disease. She has co-authored over 20 peer-reviewed publications, including in Clinical Cancer Research and Nature Cell, and is an active member of the Sarcoma Clinical Trial Working Group in the Hoosier Cancer Research Network. Her research has been supported by the Chinese American Hematologist and Oncologist Network and Sarcoma Alliance for Research through Collaboration. -
Margaret J. Zhou, MD, MS
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr. Margaret Zhou is a board-certified, fellowship-trained gastroenterologist with Stanford Health Care. She also holds an appointment as clinical assistant professor at Stanford University School of Medicine.
She specializes in therapeutic endoscopy with expertise in treating Barrett’s esophagus and disorders of the pancreas and bile duct. In particular, she offers advanced endoscopic interventions to prevent, detect, and manage gastrointestinal (GI) cancers. These interventions include endoscopic mucosal resection, endoscopic ablation, endoscopic retrograde cholangiopancreatography, and endoscopic ultrasound. She is also interested in the management of esophageal disorders such as gastroesophageal reflux disease.
Dr. Zhou has published widely on improving the detection of precancerous lesions and cancers of the GI tract. She is particularly interested in prevention, early detection, and outcomes in Barrett’s esophagus, esophageal cancer, and stomach cancer. In addition, she has published on new technologies and the use of artificial intelligence in GI. Her research has been published in multiple journals including Clinical Gastroenterology and Hepatology; Clinical and Translational Gastroenterology; and Cancer Epidemiology, Biomarkers & Prevention.
Dr. Zhou is an active member of multiple national GI societies. She currently serves on the American Gastroenterological Association (AGA) Clinical Guidelines Committee and AGA Trainee and Early Career Committee. She also serves as an Associate Editor for Evidence-Based GI, an American College of Gastroenterology (ACG) journal. -
Sa Zhou
Postdoctoral Scholar, Neurosurgery
BioSa Zhou, Ph.D., received her Ph.D. in Biomedical Engineering from The Hong Kong Polytechnic University. Her research focuses on person-centered cognitive and physical enhancement for aging-related neurological disorders - including stroke, Parkinson’s disease (PD), and Alzheimer’s disease (AD) - through the development of closed-loop brain-computer interface (BCI)-guided neuromodulation and rehabilitation robotics, as well as the investigation of brain structural and functional connectivity using multimodal neuroimaging and electrophysiology.
-
Wenhui Zhou
Adjunct Clinical Instructor, Radiology
BioWenhui was born in Southeast China and then immigrated to the San Francisco Bay Area as a teenager. He attended the University of California, Davis under a Regent Scholarship, and graduated with highest honors in Biochemistry and Molecular Biology. Wenhui subsequently pursued training in medicine and translational research in the Medical Scientist Training Program (MSTP) at Tufts University. In the Laboratory of Dr. Charlotte Kuperwasser, Wenhui studied the regulation and function of transcription factors in triple-negative breast cancer with the goal of improving cancer diagnosis and therapeutics. Additionally, he pursued clinical research examining image-guided ablative therapy as a front-line treatment option for renal cancer under the mentorship of Dr. Ronald Arellano at Massachusetts General Hospital. Outside of his clinical and academic interests, Wenhui enjoys food, taking walks, listening to NPR, and spending time with family and friends.
-
Han Zhu
Assistant Professor of Medicine (Cardiovascular Medicine)
BioDr. Zhu is an Assistant Professor of Medicine whose clinical and research expertise focuses on cardio-oncology and cardio-immunology. She specializes in the cardiovascular care of patients undergoing therapies for cancer, with a particular focus on the effects of immunotherapies on the heart. She received a bioengineering degree from MIT, medical degree from Case Western Reserve University, and completed clinical cardiology fellowship and internal medicine residency training at Stanford University School of Medicine. Dr. Zhu’s laboratory focuses on myocarditis, cardiac inflammation, and the effects of cancer therapeutics on the cardiovascular system. Her current research employs clinical data, bio-banked samples, and in vivo/in vitro preclinical models in combination with single-cell technologies to study immune-based toxicities in the heart. Dr. Zhu's clinic sees cardio-oncology and cardio-immunology patients and her lab focuses on devising new methods for minimizing cardiovascular complications in the cancer and autoimmune patient populations.
-
Wenjuan Zhu
Postdoctoral Scholar, Cardiovascular Institute
BioPostdoctoral Fellow
